These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 7554701
1. Effects of felbamate on the pharmacokinetics of phenobarbital. Reidenberg P, Glue P, Banfield CR, Colucci RD, Meehan JW, Radwanski E, Mojavarian P, Lin CC, Nezamis J, Guillaume M. Clin Pharmacol Ther; 1995 Sep; 58(3):279-87. PubMed ID: 7554701 [Abstract] [Full Text] [Related]
2. Effects of felbamate on the pharmacokinetics of the monohydroxy and dihydroxy metabolites of oxcarbazepine. Hulsman JA, Rentmeester TW, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Radwanski E, Mojaverian P, Lin CC, Nezamis J. Clin Pharmacol Ther; 1995 Oct; 58(4):383-9. PubMed ID: 7586929 [Abstract] [Full Text] [Related]
3. Effect of felbamate on the pharmacokinetics of lamotrigine. Colucci R, Glue P, Holt B, Banfield C, Reidenberg P, Meehan JW, Pai S, Nomeir A, Lim J, Lin CC, Affrime MB. J Clin Pharmacol; 1996 Jul; 36(7):634-8. PubMed ID: 8844446 [Abstract] [Full Text] [Related]
4. Potential pharmacokinetic interaction between felbamate and phenobarbital. Gidal BE, Zupanc ML. Ann Pharmacother; 1994 Apr; 28(4):455-8. PubMed ID: 8038465 [Abstract] [Full Text] [Related]
5. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation. Hooper WD, Franklin ME, Glue P, Banfield CR, Radwanski E, McLaughlin DB, McIntyre ME, Dickinson RG, Eadie MJ. Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632 [Abstract] [Full Text] [Related]
6. Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Glue P, Banfield CR, Perhach JL, Mather GG, Racha JK, Levy RH. Clin Pharmacokinet; 1997 Sep; 33(3):214-24. PubMed ID: 9314612 [Abstract] [Full Text] [Related]
7. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive. Saano V, Glue P, Banfield CR, Reidenberg P, Colucci RD, Meehan JW, Haring P, Radwanski E, Nomeir A, Lin CC. Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946 [Abstract] [Full Text] [Related]
8. Pharmacokinetic interaction studies between felbamate and vigabatrin. Reidenberg P, Glue P, Banfield C, Colucci R, Meehan J, Rey E, Radwanski E, Nomeir A, Lim J, Lin C. Br J Clin Pharmacol; 1995 Aug; 40(2):157-60. PubMed ID: 8562299 [Abstract] [Full Text] [Related]
9. Felbamate in vitro metabolism by rat liver microsomes. Adusumalli VE, Wong KK, Kucharczyk N, Sofia RD. Drug Metab Dispos; 1991 Aug; 19(6):1135-8. PubMed ID: 1687021 [Abstract] [Full Text] [Related]
10. Felbamate: a new antiepileptic drug. Wagner ML. Am J Hosp Pharm; 1994 Jul 01; 51(13):1657-66. PubMed ID: 7942890 [Abstract] [Full Text] [Related]
11. Effect of felbamate on carbamazepine and its major metabolites. Wagner ML, Remmel RP, Graves NM, Leppik IE. Clin Pharmacol Ther; 1993 May 01; 53(5):536-43. PubMed ID: 8491065 [Abstract] [Full Text] [Related]
12. Population pharmacokinetics of felbamate in children. Kelley MT, Walson PD, Cox S, Dusci LJ. Ther Drug Monit; 1997 Feb 01; 19(1):29-36. PubMed ID: 9029743 [Abstract] [Full Text] [Related]
13. Effect of felbamate on plasma levels of carbamazepine and its metabolites. Albani F, Theodore WH, Washington P, Devinsky O, Bromfield E, Porter RJ, Nice FJ. Epilepsia; 1991 Feb 01; 32(1):130-2. PubMed ID: 1985822 [Abstract] [Full Text] [Related]
14. Single and multiple dose pharmacokinetics of felbamate in the elderly. Richens A, Banfield CR, Salfi M, Nomeir A, Lin CC, Jensen P, Affrime MB, Glue P. Br J Clin Pharmacol; 1997 Aug 01; 44(2):129-34. PubMed ID: 9278196 [Abstract] [Full Text] [Related]
15. P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats. Potschka H, Fedrowitz M, Löscher W. Neurosci Lett; 2002 Jul 26; 327(3):173-6. PubMed ID: 12113905 [Abstract] [Full Text] [Related]
16. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy. Sachdeo R, Narang-Sachdeo SK, Shumaker RC, Perhach JL, Lyness WH, Rosenberg A. Epilepsia; 1997 Aug 26; 38(8):887-92. PubMed ID: 9579889 [Abstract] [Full Text] [Related]
17. Influence of felbamate on selected central effects of ethanol in experimental animals. Pietrzak B, Czarnecka E. Acta Pol Pharm; 2004 Aug 26; 61(3):209-13. PubMed ID: 15481247 [Abstract] [Full Text] [Related]
18. Selective antagonism of the anticonvulsant effects of felbamate by glycine. Coffin V, Cohen-Williams M, Barnett A. Eur J Pharmacol; 1994 Apr 21; 256(2):R9-10. PubMed ID: 8050461 [Abstract] [Full Text] [Related]
19. Effect of smoking on single dose pharmacokinetics of phenobarbital. Mirfazaelian A, Jahanzad F, Tabatabaei-far M, Farsam H, Mahmoudian M. Biopharm Drug Dispos; 2001 Dec 21; 22(9):403-6. PubMed ID: 11870679 [Abstract] [Full Text] [Related]
20. Evaluation of the potential interaction between felbamate and erythromycin in patients with epilepsy. Sachdeo RC, Narang-Sachdeo S, Montgomery PA, Shumaker RC, Perhach JL, Lyness WH, Rosenberg A. J Clin Pharmacol; 1998 Feb 21; 38(2):184-90. PubMed ID: 9549651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]